Background illustration for clinical trials search

Stem Cells Clinical Trials

Find clinical trials for stem cells. Search for stem cells clinical trials in different cities and states across the United States.

Filter

Evaluation of Plant-based Nutritional Products on Stem Cells

for
Stem Cell Mobilization, Hematopoietic Stem Cell Mobilization,
Location: Klamath Falls OR
Sponsor: Natural Immune Systems Inc

Sex: All

Age: 20 - 70+

Code: NCT03388073

Recruiting

Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors

for
Hematopoietic Stem Cell Transplant
Location: Boston MA, Durham NC, Tampa FL
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18+

Code: NCT06328127

Recruiting

Early Cognitive Behavioral Therapy for Insomnia (CBT-I) in People Planning to Under Hematopoietic Stem Cell Transplant (HSCT)

for
Hematopoietic Stem Cell Transplant
Location: Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 18+

Code: NCT07774039

Phase 1, Recruiting

eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation

for
Stem Cell Transplantation, Myelodysplastic Syndromes,
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT07469592

Recruiting

Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency

for
Limbal Stem Cell Deficiency
Location: South Dartmouth MA, Rockville Centre NY,
Sponsor: Claris Biotherapeutics, Inc.

Sex: All

Age: 12 - 70+

Code: NCT07636590

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Supportive Care Intervention for Outpatient Stem Cell Transplant Patients

for
Hematopoietic Stem Cell Transplantation, Cancer
Location: Boston MA
Sponsor: Victor Wang

Sex: All

Age: 19+

Code: NCT06564233

Recruiting

Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention

for
Graft-versus-Host Disease (GVHD), Hematologic Malignancies,
Location: Hershey PA
Sponsor: Milton S. Hershey Medical Center

Sex: All

Age: 18+

Code: NCT06926595

Phase 2, Recruiting

Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Standard of Care Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Study

for
Stem Cell
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06004063

Recruiting

Prevention of Graft Rejection in Hematopoietic Stem Cell Transplant (HSCT) Recipients

for
Hematopoietic Stem Cell Transplantation, Graft Failure
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0+

Code: NCT07244419

Early Phase 1, Recruiting

Zoledronate to Prevent Bone Health Complications in Pediatric Hematopoietic Stem Cell Transplant Survivors

for
Hematopoietic Stem Cell Transplantation
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 5 - 18

Code: NCT07375290

Phase 1, Recruiting

Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

for
Allogeneic Stem Cell Transplant Recipient
Location: Hackensack NJ
Sponsor: Hackensack Meridian Health

Sex: All

Age: 18 - 65

Code: NCT07214688

Phase 2, Recruiting

A Study Testing an Improved Dose of UM171 to Help Make Cord Blood Transplants More Effective and Safe.

for
Acute Leukemia, High Risk, Myelodysplastic Syndromes, High Risk,
Location: Montreal
Sponsor: Ciusss de L'Est de l'Île de Montréal

Sex: All

Age: 18 - 67

Code: NCT07301866

Phase 1, Phase 2, Recruiting

Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation

for
Kidney Failure Chronic, Stem Cell Transplant,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18 - 70

Code: NCT07358195

Early Phase 1, Recruiting

Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT

for
Allogeneic Hematopoietic Stem Cell Transplantation Recipient,
Location: Columbus OH
Sponsor: Sumithira Vasu

Sex: All

Age: 1 - 70+

Code: NCT03665675

Early Phase 1, Recruiting

Enteral Nutrition Versus Standard of Care in Allogeneic Hematopoietic Stem Cell Transplantation

for
Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT)
Location: Omaha NE
Sponsor: University of Nebraska

Sex: All

Age: 19+

Code: NCT07315165

Phase 2, Recruiting

Ivosidenib as Post-HSCT Maintenance for AML

for
IDH1 Mutation, Acute Myeloid Leukemia (AML),
Location: Boston MA, Columbus OH, Atlanta GA, Milwaukee WI,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18 - 70+

Code: NCT06707493

Phase 2, Recruiting

Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging

for
Allogeneic Stem Cell Transplantation,
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 18 - 70+

Code: NCT07613099

Phase 3, Recruiting

Prospective Observational Study of Outcomes After Gemcitabine, Docetaxel, Melphalan, and Carboplatin With Autologous Stem Cell Transplantation in Pediatric Relapsed/Refractory Germ Cell Tumors

for
Prospective Observational Study, Gemcitabine, Docetaxel,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 21+

Code: NCT07662018

Recruiting

Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States

for
Hematopoietic Stem Cell Transplantation, Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05681026

Recruiting

Aromatherapy Inhaler Use for HSCT Distress

for
Cancer Distress, Cancer Coping,
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT05302583

Recruiting

What stem cell therapy clinical trials are studying now

Transplants for blood cancers and blood disorders. Hematopoietic stem cell transplant replaces a person's blood forming system with their own stored cells or a donor's. Trials test safer conditioning, better donor matching, including half matched family donors for sickle cell disease, and ways to prevent graft versus host disease.

Transplants for autoimmune disease. Resetting the immune system with a person's own stem cells is being tested against the best available drugs in relapsing multiple sclerosis, in a Phase 3 trial funded by the National Institutes of Health at more than 20 US sites.

Mesenchymal stromal cells. Cells from bone marrow or fat that calm inflammation, tested for Crohn's disease, graft versus host disease, and hard to heal wounds. The first one was approved in 2024 after decades of trials.

Cells made from stem cells. Lab grown dopamine neurons for Parkinson's disease and insulin producing islet cells for type 1 diabetes, both now in or entering late stage trials.

Gene corrected stem cells. A person's own blood stem cells are edited to fix a mutation and returned. Two such therapies for sickle cell disease were approved in 2023; see gene therapy clinical trials. Immune cell therapies such as CAR T are a different technology, covered on our CAR T cell therapy page.

Stem cell transplants are part of care for leukemia, lymphoma, and multiple myeloma; each page lists its own studies.

Article preview image

New to research? Read how informed consent works.

Informed Consent in Clinical Trials: What Is It and How It’s Obtained

Who can participate in stem cell therapy clinical trials?

Is stem cell therapy safe?

How long does stem cell therapy last?

Do stem cell trial participants get paid?

How to enroll in a stem cell clinical trial